Rezolute Inc Ordinary Shares RZLT 深 滬
已收盤 09-20 16:00:00 美东时间
5.08
+0.260
+5.39%
華盛通- 最 高5.44
- 今 開5.21
- 成交量 151.34万股
- 最 低 4.82
- 昨 收 4.82
- 總市值 2.81亿
- 52周最高 6.0999
- 市盈率 靜 --
- 換手率 2.73%
- 52周最低 0.72
- 委 比 -96.64%
- 總股本 5536.98万
- 歷史最高 21.11
- 量 比 4.77
- 振 幅 12.86%
- 歷史最低 0.72
- 每 手 1
- 風險率 1.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Rezolute Q4 2024 GAAP EPS $(0.44) Misses $(0.32) Estimate
Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.32) by 37.5 percent.
09-20 04:07
HC Wainwright & Co. Reiterates Buy on Rezolute, Maintains $14 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.
09-10 01:25
FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment
FDA lifts clinical hold on Rezolute's RZ358 for treating congenital hyperinsulinism, allowing U.S. participants in Phase 3 study. Enrollment expected to start in 2025 with topline data by mid-year.
09-09 22:41
Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy
Rezolute (NASDAQ:RZLT) shares gained 13% Monday morning as the U.S. FDA lifted its partial clinical hold on the firm's investigational therapy for hypoglycemia caused by congenital hyperinsulinism. RZ...
09-09 21:39
Rezolute’s RZ358 Advances with FDA Clearance for Study
Rezolute ( ($RZLT) ) has issued an update. Rezolute, Inc. has made a significan...
09-09 19:57
Rezolute gets FDA okay for Phase 3 ersodetug registrational study
Rezolute (NASDAQ:RZLT) said it has received FDA clearance of its Investigational New Drug application for a Phase 3 registrational study of its drug RZ358, or ersodetug, for the treatment of hypoglyce...
08-06 01:54
Rezolute Receives FDA Nod for Hypoglycemia Drug RZ358
An announcement from Rezolute (RZLT) is now available. Rezolute, Inc. announced...
08-05 19:58
Rezolute Shares Updated RZ402 Data Presentation Online
An update from Rezolute (RZLT) is now available. Rezolute, Inc. has updated its...
06-29 05:48
Rezolute Secures Funding Through Private Placement Deal
Rezolute (RZLT) has issued an update. On June 25, 2024, a company engaged in a ...
06-27 20:28
Rezolute Raises $60M to Fund Research and Corporate Goals
The latest announcement is out from Rezolute (RZLT). Rezolute, Inc. has partner...
06-15 05:59
